Rating History for Eli Lilly (lly) by Berenberg
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/15/2026 | Kerry Holford | Upgrade | Buy (Hold) |
1,400.00 (1,220.00) |
1115.70 (1186.54) |
6.35% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/15/2026 | Kerry Holford | Upgrade | Buy (Hold) |
1,400.00 (1,220.00) |
1115.70 (1186.54) |
6.35% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||